Stavanger University Hospital Inflammatory Bowel Disease Trial
Recruiting
Observational Study
IBD
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 700 (estimated)
- Sponsor
- Helse Stavanger HF · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* newly diagnosed IBD
Exclusion Criteria:
* previous IBD with specific treatment within 10 year
* inability to consent
* inability to adhere to treatment protocol
Contacts